| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 95.41▲ | 95.17▲ | 94.55▲ | 92.27▲ | 90.70▲ |
| MA10 | 95.19▲ | 94.42▲ | 93.40▲ | 91.63▲ | 84.37▲ |
| MA20 | 95.00▲ | 93.33▲ | 92.39▲ | 89.79▲ | 78.07▲ |
| MA50 | 94.22▲ | 92.05▲ | 91.69▲ | 82.17▲ | 69.27▲ |
| MA100 | 93.28▲ | 91.66▲ | 90.74▲ | 76.65▲ | 64.69▲ |
| MA200 | 92.40▲ | 90.74▲ | 88.78▲ | 70.20▲ | 61.78▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.041▲ | 0.278▲ | 0.410▲ | -0.033▼ | 1.867▲ |
| RSI | 72.085▲ | 83.774▲ | 79.076▲ | 77.486▲ | 86.329▲ |
| STOCH | 74.475 | 95.599▲ | 90.616▲ | 73.336 | 92.178▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -1.874▲ | -0.596▲ |
| CCI | 234.720▲ | 137.660▲ | 170.717▲ | 261.474▲ | 113.964▲ |
|
Wednesday, October 18, 2017 12:18 PM
NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Harpoon Therapeutics, a biotechnology company developing novel T-cell recruiting biologic therapies ...
|
|
Wednesday, October 18, 2017 07:29 AM
AbbVie (NYSE:ABBV) is up 1% premarket on average volume on the heels of the announcement that it has inked an immuno-oncology (I/O) research collaboration with Arix Bioscience unit Harpoon Therapeutics. The partnership will leverage Harpoon's tri ...
|
|
Wednesday, October 18, 2017 06:45 AM
and AbbVie (NYSE: ABBV) have entered into an immune-oncology research collaboration. The goal of the research collaboration is to incorporate Harpoon's novel tri-specific T-cell activating construct (TriTAC™) platform with AbbVie's research-stage immune ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/10/17 | 92.35 | 96.21 | 92.20 | 96.05 | 6,478,953 |
| 17/10/17 | 91.09 | 92.78 | 90.95 | 92.17 | 4,790,575 |
| 16/10/17 | 91.01 | 91.99 | 90.56 | 91.02 | 4,033,332 |
| 13/10/17 | 91.41 | 91.85 | 90.54 | 90.67 | 6,781,255 |
| 12/10/17 | 91.77 | 91.99 | 90.91 | 91.42 | 4,679,292 |
| 11/10/17 | 91.47 | 92.61 | 90.97 | 92.38 | 5,962,173 |
| 10/10/17 | 90.71 | 91.22 | 89.70 | 91.17 | 3,558,996 |
| 09/10/17 | 90.57 | 91.19 | 90.15 | 90.78 | 4,329,593 |
| 06/10/17 | 90.20 | 91.33 | 89.95 | 90.49 | 3,461,397 |
| 05/10/17 | 89.69 | 90.56 | 89.48 | 90.19 | 3,749,414 |
|
|
||||
|
|
||||
|
|
||||
|
|